Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) EBT Margin (2019 - 2025)

Historic EBT Margin for Eton Pharmaceuticals (ETON) over the last 7 years, with Q3 2025 value amounting to 8.7%.

  • Eton Pharmaceuticals' EBT Margin fell 135600.0% to 8.7% in Q3 2025 from the same period last year, while for Sep 2025 it was 11.83%, marking a year-over-year decrease of 25400.0%. This contributed to the annual value of 9.76% for FY2024, which is 75800.0% down from last year.
  • Per Eton Pharmaceuticals' latest filing, its EBT Margin stood at 8.7% for Q3 2025, which was down 135600.0% from 13.31% recorded in Q2 2025.
  • Eton Pharmaceuticals' EBT Margin's 5-year high stood at 43.0% during Q1 2021, with a 5-year trough of 786.32% in Q3 2021.
  • Its 5-year average for EBT Margin is 69.87%, with a median of 10.18% in 2024.
  • Over the last 5 years, Eton Pharmaceuticals' EBT Margin had its largest YoY gain of 235842700bps in 2021, and its largest YoY loss of 2000000000bps in 2021.
  • Quarter analysis of 5 years shows Eton Pharmaceuticals' EBT Margin stood at 17.05% in 2021, then plummeted by -37bps to 10.73% in 2022, then tumbled by -163bps to 6.74% in 2023, then soared by 35bps to 4.39% in 2024, then crashed by -98bps to 8.7% in 2025.
  • Its EBT Margin was 8.7% in Q3 2025, compared to 13.31% in Q2 2025 and 83.87% in Q1 2025.